In human platelets, prostaglandin E1 and forskolin inhibit 5-hydroxytryptamine-induced phospholipase C, C-kinase and myosin light-chain kinase activity in a concentration-dependent way. Phospholipase C activation, however, was only partly inhibited, and this at higher concentrations than the protein kinases. Direct activation of the C kinase either by exogenous synthetic diacylglycerol or by 12-0-tetradecanoylphorbol 13-acetate was antagonized by prostaglandin E1 and forskolin. Since C-kinase activation is one of the key events in excitatory signal transduction in the platelets, we suggest that the inhibitory effect of agents that increase platelet cyclic AMP on platelet secretion and aggregation might reside in their capacity to antagonize C-kinase activity.
INTRODUCTION
Platelets, like many other cells, have a bidirectional control system for transduction of an extracellular signal to the cell interior. Platelet activation by excitatory stimuli coincides with an increase in intracellular Ca2+ [1] [2] [3] [4] that initiates the cellular response; inhibitory stimuli provoke an increase in cyclic AMP and inhibit the Ca2+-induced response [5] [6] [7] [8] [9] . The inhibitory effect was suggested to be due to a decrease in cellular free Ca2+ [3, 10, 11] , either by a decreased mobilization [12] or an accelerated removal [13] . At the biochemical level, excitatory stimuli such as thrombin, collagen, plateletactivating factor, ADP and 5-hydroxytryptamine [14] [15] [16] [17] [18] induce rapid changes in inositol-lipid metabolism, most probably by the action of phospholipase C [Scheme 1, (1*)]. Diacylglycerol, a second messenger thus formed, (5) (6) (8) CDP-DAG --Pi -=---PIPPPl P2 (7)
\2() (1) (1*) PAZ DAG > \ OAG C-kinase TPA 40 kDa protein 40 kDa protein-P Scheme 1. The inositol phospholipid cycle (1) Phospholipase C; (2) C-kinase activation; (3) diacylglycerol kinase; (4) CTP: phosphatide cytidylyltransferase; (5) CDP: 1,2-diacylglycerol-inositol phosphatidyltransferase; (6) PI kinase; (7) PIP phosphomonoesterase; (8) PIP kinase; (9) PIP2 phosphomonoesterase.
activates the C kinase that catalyses the phosphorylation of a 40 kDa protein [Scheme 1, (2)] [19] . It was suggested that the inhibitory stimuli inhibit phospholipase C [20, 21] or diminish the re-synthesis of polyphosphoinositides that are substrates for the enzyme [9, 22] [Scheme 1 (5}- (9)]. Both effects result in a decreased generation of second-messenger diacylglycerol and a concomitant decrease of C kinase activity. Prostaglandins (i.e. PGE1, PGD2, PGI2) and forskolin (FK) are commonly used inhibitory platelet stimuli [5, [23] [24] [25] . They increase cellular cyclic AMP [5, [23] [24] [25] and, as a consequence, several proteins become rapidly phosphorylated, most probably through the activation of a cyclic-AMP-dependent protein kinase [13, [26] [27] [28] [29] . The C kinase can be activated directly by 1-oleoyl-2-acetylglycerol (OAG) and 12-0-tetradecanoylphorbol 13-acetate (TPA) [30, 31] [Scheme 1, (2)]. In the present paper we demonstrate that agents that are known to increase cellular cyclic AMP antagonize the activation of the C kinase. As described previously [18] , 32P-labelled phospholipids were located on the sheets after overnight autoradiography on Kodak X-Omat films; they were cut out and the radioactivity was quantified by liquidscintillation spectrometry. Measurement of 32P-labelied proteins Platelet samples (4 x 107 platelets) were quenched in a 5-fold-concentrated sample buffer [35] and incubated at 90°C for 5 min. Proteins were separated by SDS/polyacrylamide-gel electrophoresis in a 12.5% -acrylamide gel by using the Laemmli [35] 
RESULTS
The signal-transducing system ofthe platelet serotonin-S2 receptor involves inositol-lipid metabolism [18, 36] . (Fig. 2 ).
In view of the higher inhibitory potency of PGE1 as compared with FK, we used the former compound to increase platelet cyclic AMP in further experimental work. Table 1 shows that maximum concentrations of cyclic AMP were attained 5 s after addition of PGE, (1 #M) and that they remained elevated for at least 55 s. The increase in 32P-labelled 40 kDa protein, 20 kDa protein and PA owing to stimulation with 5-hydroxytryptamine was taken as 100%; '% stimulation' was calculated by analogy with the method described in ref. [18] . For the 40 kDa protein the increase in phosphorylation was 85.8 + 8.3%, for 20 kDa protein it was 109.6 + 11.2%, and for PA formation 187.5 + 13.3% (all means +s.E.M.; n = 5). PGE1 and FK had no effect on [32P]PA in unstimulated platelets [52] . To evaluate the possibility that PGE1 affects the metabolism of OAG, leading to lower OAG concentrations and a concomitant decrease in C-kinase activity, we replaced OAG by the phorbol ester TPA, which is not readily metabolized. Fig. 4 illustrates that TPA-induced 40 kDaprotein phosphorylation is also decreased on addition of PGE1 (1 /tM), but less markedly so than in the experiment with OAG.
To gain further insight into the working mechanism, we investigated the effect of different concentrations of PGE1 on OAG-stimulated [30, 37] and basal 40 kDa-and 20 kDa-protein phosphorylation. We selected OAG instead of TPA as C-kinase activator, since this synthetic diacylglycerol more closely resembles the natural cofactor of the enzyme. Fig. 5 After 10 s OAG (in DMSO, final concn. 1%) was added and the incubation proceeded for 35 s, after which it was stopped as described in Fig. 1 . The control 32p incorporation was taken as 100% PGE, itself had no effect on 40 kDa-protein phosphorylation (see also Fig. 6 ). Points represent means + S.E.M. for three experiments with duplicate samples. Data were calculated as described in the Experimental section. [39, 40] and to impair severely excitatory stimulation of platelets [41] [42] [43] . Fig. 6 illustrates the effect of intracellular Ca2+ complexation by quin 2 on stimulation of human platelets with 5-hydroxytryptamine. In the presence of 50 /tM-quin-2/ AM (corresponds to 5-8 mm intracellular quin-2), the 5-hydroxytryptamine-induced PA formation and 40 kDa-protein phosphorylation were nearly completely abolished, indicating that the Ca2+ requirements for the activation of phospholipase C are no longer fulfilled. Fig.  7 illustrates the effect of intracellular Ca2+ complexation on direct activation of the protein kinase C. The OAG-induced 40 DISCUSSION Agents that increase platelet cyclic AMP were suggested to inhibit the receptor-coupled polyphosphoinositide-specific phospholipase C [20, 21] or to diminish the re-synthesis of its substrates [9, 22] . Fig. 1 shows that such a mechanism is activated by PGE1 (1 pum; 0) or their carriers (0 Vol. 244
by PGE1 and FK. Myosin light-chain kinase is a Ca2+-calmodulin-dependent enzyme [44] . The effects of these compounds on the amount of 32P-labelled 20 kDa protein are therefore consistent with their antagonistic effect on Ca2+ mobilization [4] . In the human platelet, 5-hydroxytryptamine induces shape changes and reversible aggregation without secretion [45] ; the cellular free Ca2+ concentrations are raised [4] . Previous reports [4, 46] showed that these phenomena were inhibited by PGE1 and FK in the concentration range in which they inhibit 5-hydroxytryptamine-induced increases in 40 kDa-and 20 kDaprotein phosphorylation and PA formation (Fig. 1) . More surprising, however, was our finding that higher concentrations on PGE1 and FK were needed to block PA formation only partially than to affect protein phosphorylation (Fig. 1) . Similar data were obtained when platelets were stimulated with thrombin in the presence of prostacyclin [9] . At high concentrations of the prostaglandin, aggregation was abolished, whereas the inositol phosphate release, which is a measure for phospholipase C or a preceding metabolic step, was not completely inhibited [9] . As an alternative mechanism for the only partial decrease in PA formation, an accelerated conversion of PA into PI [Scheme 1 (4) and (5) [49] found that agents that increase platelet cyclic AMP more potently antagonized the dense-granule ATP secretion induced by OAG than the release induced by TPA. In the same paper these authors show that the collagen-provoked ATP release in the presence of indomethacin is not inhibited by FK. More recently, Lapetina's group [50] illustrated that, in these conditions, protein kinase C is not activated, which explains why FK could have no inhibitory effect.
The experiment in which the PGE,-concentrationdependence of this phenomenon is elaborated (Fig. 5) shows that the 32p content of the 40 kDa protein in the unstimulated platelet remains unaffected; the stimulated C-kinase activation, however, was inhibited by PGE1 in a dose-dependent way. The concentration of PGE1 necessary to obtain half-maximal inhibition of OAGinduced 40 kDa-protein phosphorylation (approx. 22 nM; Fig. 5 ) was higher than that required to obtain half-maximal inhibition of 5-hydroxytryptamine-induced 40 kDa-protein phosphorylation (approx. 4.6 nM; Fig.   1 ). These data are in accordance with those on ATP secretion [49] that illustrated a higher inhibitory effect on thrombin-induced ATP secretion of agents that increase platelet cyclic AMP compared with that evoked by OAG.
It is tempting to conclude from our data that the decrease in 32P content is not caused by a direct effect on either the kinase or the phosphatase activity, since that would also affect the 40 kDa-protein phosphorylation in unstimulated platelets, as can be seen for 20 kDa-protein phosphorylation. However, our knowledge about the function of 40 kDa protein is too poor to exclude that kinase/phosphatase systems other than that involved in protein kinase C activation contribute to the 32P content of the 40 kDa protein in resting platelets. A direct effect on either the protein kinase C or a phosphatase should therefore still be envisaged. The effect of PGE1 on 20 kDa-protein phosphorylation is clearly different. The basal as well as the OAG-stimulated phosphorylation decrease below the control value. A direct effect on the phosphorylation/dephosphorylation processes is hence apparent. Since the myosin light-chain kinase is a Ca2+-calmodulin-dependent enzyme [44] and is probably responsible for basal extents of phosphorylation, decreased intracellular Ca2+ [3, 4, 10, 13, 26] might explain these observations.
By analogy with the myosin light-chain kinase, the intracellular Ca2+ concentrations might determine the protein kinase C activity, as was found by other investigators [19, 38] . The experiment described in Figs. 6 and 7, in which we used quin 2 to decrease the intracellular-Ca2+ concentration, demonstrated that, under conditions in which phospholipase C activity was nearly completely abolished (Fig. 6) , protein kinase C activity retained approx. 70 % of its phosphorylating capacity (Fig. 7) . In case the antagonistic effect on 40 kDa-protein phosphorylation of compounds that increase platelet cyclic AMP is due to a decrease in intracellular free Ca2+ concentration, these compounds would antagonize phospholipase C activity more potently than protein kinase C activity. The experiment described in Fig. 1 , on the contrary, illustrates that higher concentrations of either PGE1 or FK are required to inhibit PA formation activity only partly than to decrease 40 kDa protein phosphorylation.
We can therefore conclude that a PGE1-or FK-induced decrease in platelet intracellular free Ca2+ plays only a minor role in the antagonistic effect of these compounds on protein kinase C activity.
It is unknown to what extent compounds that increase cyclic AMP can reverse C-kinase activation by a physiological agonist. On stimulation with 5-hydroxytryptamine (5S,M), the increase in 40 kDa-protein [32P]phosphorylation was approx. 85%, which is similar to that with 30 nM-TPA (Fig. 4) and less than that by 3 /SM-OAG (Fig. 3) . At these concentrations of TPA and OAG, C-kinase activation was abolished by PGE1 (Figs. 3 and 4) . It is therefore highly suggestive that the discrepancy that we found between the PGE1-or FK-induced decrease in 40 kDa-protein phosphorylation on the one hand and PA formation on the other (Fig. 1) will be due to the antagonistic effect that we found to occur at the level of the C kinase. The finding that one pathway of the bifurcating excitatory signal-transduction system in platelets is antagonized by compounds that increase cyclic AMP might be the key event in the anti-aggregatory effect of these compounds.
To our knowledge, our data provide the first biochemical evidence that compounds known to increase platelet cyclic AMP can have an inhibitory effect in the excitatory signal transduction at a site beyond phospho-lipase C at the level of the C kinase. It should be mentioned that an inhibitory site for cyclic AMP beyond phospholipase C has been suggested, but based on physiological evidence, from a study on the effect of increased cyclic AMP on platelet secretion [51] . The precise nature of this mechanism, however, remains to be elucidated.
Whether or not cyclic AMP is causally related to the effects seen in our study with PGE1 and FK cannot be decided from the present work. These compounds might indeed affect other processes besides an increase in cyclic AMP.
